+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Human Microbiome Market Research Report by Disease (Acute Diarrhea, Autoimmune Disorders, and Cancer), Technology, Product, Therapeutic Area, Application, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4857894
  • Report
  • April 2022
  • Region: Global
  • 183 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • 4D pharma PLC
  • DuPont de Nemours, Inc.
  • Exeliom Biosciences SAS
  • Locus Biosciences, Inc.
  • Osel Inc.
  • Synlogic, Inc.
The Global Human Microbiome Market size was estimated at USD 867.68 million in 2020, USD 1,053.28 million in 2021, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 23.13% to reach USD 3,724.81 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Human Microbiome to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Disease, the market was studied across Acute Diarrhea, Autoimmune Disorders, Cancer, Diabetes, Mental Disorders, and Obesity.
  • Based on Technology, the market was studied across 16s rRNA Sequencing, Cell Culture Technology, Computational Tools, High-Throughput Technology, Metagenomic Sequencing, and Omics Technology.
  • Based on Product, the market was studied across Diagnostic Devices, Drugs, Foods, and Prebiotic & Probiotics.
  • Based on Therapeutic Area, the market was studied across Gastrointestinal Disorders, Metabolic Disorders, Skin Disorders, and Women’s Health.
  • Based on Application, the market was studied across Diagnostics and Therapeutics.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Connecticut, Florida, Illinois, Maryland, Minnesota, New Jersey, New York, Ohio, Pennsylvania, Texas, and Washington. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Human Microbiome Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Human Microbiome Market, including 4D pharma PLC, AOBiome, LLC, Astarte Medical Partners, Inc, Axial Therapeutics, Inc., DuPont de Nemours, Inc., Enterome Bioscience, Evelo Biosciences, Inc., Exeliom Biosciences SAS, Ferring B.V., Finch Therapeutics Group, Inc., Intralytix, Inc., Locus Biosciences, Inc., Merck and Co. Inc., Metabiomics Corporation, Osel Inc., Second Genome, Inc., Seres Therapeutics, Inc., Synlogic, Inc., Synthetic Biologics, Inc., Vedanta Biosciences, Inc., and Yakult Honsha Co., Ltd..

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Human Microbiome Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Human Microbiome Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Human Microbiome Market?
4. What is the competitive strategic window for opportunities in the Global Human Microbiome Market?
5. What are the technology trends and regulatory frameworks in the Global Human Microbiome Market?
6. What is the market share of the leading vendors in the Global Human Microbiome Market?
7. What modes and strategic moves are considered suitable for entering the Global Human Microbiome Market?
Frequently Asked Questions about the Global Human Microbiome Market

What is the estimated value of the Global Human Microbiome Market?

The Global Human Microbiome Market was estimated to be valued at $867.7 Million in 2020.

What is the growth rate of the Global Human Microbiome Market?

The growth rate of the Global Human Microbiome Market is 23.1%, with an estimated value of $3724.8 Million by 2027.

What is the forecasted size of the Global Human Microbiome Market?

The Global Human Microbiome Market is estimated to be worth $3724.8 Million by 2027.

Who are the key companies in the Global Human Microbiome Market?

Key companies in the Global Human Microbiome Market include 4D pharma PLC, AOBiome, LLC, Astarte Medical Partners, Inc, Axial Therapeutics, Inc., DuPont de Nemours, Inc., Enterome Bioscience, Evelo Biosciences, Inc., Exeliom Biosciences SAS and Finch Therapeutics Group, Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • 4D pharma PLC
  • DuPont de Nemours, Inc.
  • Exeliom Biosciences SAS
  • Locus Biosciences, Inc.
  • Osel Inc.
  • Synlogic, Inc.

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increased Focus on Human Microbiome Therapy
5.1.1.2. Human Microbiome for Drug Discovery, Early Disease Detection, and Diagnosis
5.1.1.3. Increasing Demand for Microbiome in Probiotics and Infant Nutrition
5.1.2. Restraints
5.1.2.1. Limited Expertise and Safety Issue related to Microbiome Therapeutics
5.1.3. Opportunities
5.1.3.1. Increasing Collaborations and Research Investments to Create Growth Opportunities
5.1.3.2. Development of Novel Human Microbiome Therapeutic Products
5.1.4. Challenges
5.1.4.1. Lack of Uncertainty related to Drug Performance and Limited Studies Proving Causal Links between Microbiota Dysbiosis and Disease
5.2. Cumulative Impact of COVID-19
6. Human Microbiome Market, by Disease
6.1. Introduction
6.2. Acute Diarrhea
6.3. Autoimmune Disorders
6.4. Cancer
6.5. Diabetes
6.6. Mental Disorders
6.7. Obesity
7. Human Microbiome Market, by Technology
7.1. Introduction
7.2. 16s rRNA Sequencing
7.3. Cell Culture Technology
7.4. Computational Tools
7.5. High-Throughput Technology
7.6. Metagenomic Sequencing
7.7. Omics Technology
8. Human Microbiome Market, by Product
8.1. Introduction
8.2. Diagnostic Devices
8.3. Drugs
8.4. Foods
8.5. Prebiotic & Probiotics
9. Human Microbiome Market, by Therapeutic Area
9.1. Introduction
9.2. Gastrointestinal Disorders
9.3. Metabolic Disorders
9.4. Skin Disorders
9.5. Women’s Health
10. Human Microbiome Market, by Application
10.1. Introduction
10.2. Diagnostics
10.3. Therapeutics
11. Americas Human Microbiome Market
11.1. Introduction
11.2. Argentina
11.3. Brazil
11.4. Canada
11.5. Mexico
11.6. United States
12. Asia-Pacific Human Microbiome Market
12.1. Introduction
12.2. Australia
12.3. China
12.4. India
12.5. Indonesia
12.6. Japan
12.7. Malaysia
12.8. Philippines
12.9. Singapore
12.10. South Korea
12.11. Taiwan
12.12. Thailand
13. Europe, Middle East & Africa Human Microbiome Market
13.1. Introduction
13.2. France
13.3. Germany
13.4. Italy
13.5. Netherlands
13.6. Qatar
13.7. Russia
13.8. Saudi Arabia
13.9. South Africa
13.10. Spain
13.11. United Arab Emirates
13.12. United Kingdom
14. Competitive Landscape
14.1. FPNV Positioning Matrix
14.1.1. Quadrants
14.1.2. Business Strategy
14.1.3. Product Satisfaction
14.2. Market Ranking Analysis
14.3. Market Share Analysis, By Key Player
14.4. Competitive Scenario
14.4.1. Merger & Acquisition
14.4.2. Agreement, Collaboration, & Partnership
14.4.3. New Product Launch & Enhancement
14.4.4. Investment & Funding
14.4.5. Award, Recognition, & Expansion
15. Company Usability Profiles
15.1. 4D pharma PLC
15.2. AOBiome, LLC
15.3. Astarte Medical Partners, Inc
15.4. Axial Therapeutics, Inc.
15.5. DuPont de Nemours, Inc.
15.6. Enterome Bioscience
15.7. Evelo Biosciences, Inc.
15.8. Exeliom Biosciences SAS
15.9. Ferring B.V.
15.10. Finch Therapeutics Group, Inc.
15.11. Intralytix, Inc.
15.12. Locus Biosciences, Inc.
15.13. Merck and Co. Inc.
15.14. Metabiomics Corporation
15.15. Osel Inc.
15.16. Second Genome, Inc.
15.17. Seres Therapeutics, Inc.
15.18. Synlogic, Inc.
15.19. Synthetic Biologics, Inc.
15.20. Vedanta Biosciences, Inc.
15.21. Yakult Honsha Co., Ltd.
16. Appendix
16.1. Discussion Guide
16.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL HUMAN MICROBIOME MARKET: DYNAMICS
FIGURE 2. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2020 VS 2027 (%)
FIGURE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2020 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2027
FIGURE 5. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, 2018-2027 (USD MILLION)
FIGURE 6. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, 2018-2027 (USD MILLION)
FIGURE 8. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, 2018-2027 (USD MILLION)
FIGURE 10. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 11. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, 2018-2027 (USD MILLION)
FIGURE 12. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 13. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, 2018-2027 (USD MILLION)
FIGURE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 15. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, 2018-2027 (USD MILLION)
FIGURE 16. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 17. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (%)
FIGURE 18. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2020 VS 2027 (USD MILLION)
FIGURE 19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 20. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, 2018-2027 (USD MILLION)
FIGURE 21. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 22. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, 2018-2027 (USD MILLION)
FIGURE 23. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, 2018-2027 (USD MILLION)
FIGURE 25. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 26. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, 2018-2027 (USD MILLION)
FIGURE 27. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 28. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, 2018-2027 (USD MILLION)
FIGURE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 30. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, 2018-2027 (USD MILLION)
FIGURE 31. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 32. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2020 VS 2027 (%)
FIGURE 33. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2020 VS 2027 (USD MILLION)
FIGURE 34. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2027
FIGURE 35. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, 2018-2027 (USD MILLION)
FIGURE 36. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 37. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, 2018-2027 (USD MILLION)
FIGURE 38. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 39. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, 2018-2027 (USD MILLION)
FIGURE 40. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 41. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, 2018-2027 (USD MILLION)
FIGURE 42. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 43. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2020 VS 2027 (%)
FIGURE 44. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2020 VS 2027 (USD MILLION)
FIGURE 45. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2027
FIGURE 46. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, 2018-2027 (USD MILLION)
FIGURE 47. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 48. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, 2018-2027 (USD MILLION)
FIGURE 49. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 50. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, 2018-2027 (USD MILLION)
FIGURE 51. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 52. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, 2018-2027 (USD MILLION)
FIGURE 53. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 54. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2020 VS 2027 (%)
FIGURE 55. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2020 VS 2027 (USD MILLION)
FIGURE 56. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2027
FIGURE 57. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, 2018-2027 (USD MILLION)
FIGURE 58. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 59. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, 2018-2027 (USD MILLION)
FIGURE 60. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2020 VS 2027 (USD MILLION)
FIGURE 61. AMERICAS HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 62. ARGENTINA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 63. BRAZIL HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 64. CANADA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 65. MEXICO HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 66. UNITED STATES HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 67. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 68. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 69. CHINA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 70. INDIA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 71. INDONESIA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 72. JAPAN HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 73. MALAYSIA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 74. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 75. SINGAPORE HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 76. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 77. TAIWAN HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 78. THAILAND HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 79. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 80. FRANCE HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 81. GERMANY HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 82. ITALY HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 83. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 84. QATAR HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 85. RUSSIA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 86. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 87. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 88. SPAIN HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 89. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 90. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
FIGURE 91. GLOBAL HUMAN MICROBIOME MARKET: FPNV POSITIONING MATRIX
FIGURE 92. GLOBAL HUMAN MICROBIOME MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 93. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL HUMAN MICROBIOME MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL HUMAN MICROBIOME MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DISEASE, 2018-2027 (USD MILLION)
TABLE 4. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY REGION, 2018-2027 (USD MILLION)
TABLE 5. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 6. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY STATE, 2018-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY ACUTE DIARRHEA, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 9. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 10. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 11. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY AUTOIMMUNE DISORDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 14. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY REGION, 2018-2027 (USD MILLION)
TABLE 15. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 16. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY STATE, 2018-2027 (USD MILLION)
TABLE 17. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 18. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY CANCER, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 19. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY REGION, 2018-2027 (USD MILLION)
TABLE 20. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 21. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY STATE, 2018-2027 (USD MILLION)
TABLE 22. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 23. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DIABETES, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 24. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 25. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 26. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 27. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 28. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY MENTAL DISORDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 29. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY REGION, 2018-2027 (USD MILLION)
TABLE 30. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 31. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY STATE, 2018-2027 (USD MILLION)
TABLE 32. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 33. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY OBESITY, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 34. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY TECHNOLOGY, 2018-2027 (USD MILLION)
TABLE 35. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY REGION, 2018-2027 (USD MILLION)
TABLE 36. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 37. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY STATE, 2018-2027 (USD MILLION)
TABLE 38. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 39. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY 16S RRNA SEQUENCING, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 40. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 41. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 42. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY STATE, 2018-2027 (USD MILLION)
TABLE 43. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 44. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY CELL CULTURE TECHNOLOGY, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 45. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY REGION, 2018-2027 (USD MILLION)
TABLE 46. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 47. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY STATE, 2018-2027 (USD MILLION)
TABLE 48. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 49. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY COMPUTATIONAL TOOLS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 50. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 51. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 52. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY STATE, 2018-2027 (USD MILLION)
TABLE 53. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 54. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY HIGH-THROUGHPUT TECHNOLOGY, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 55. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY REGION, 2018-2027 (USD MILLION)
TABLE 56. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 57. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY STATE, 2018-2027 (USD MILLION)
TABLE 58. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 59. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY METAGENOMIC SEQUENCING, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 60. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY REGION, 2018-2027 (USD MILLION)
TABLE 61. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 62. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY STATE, 2018-2027 (USD MILLION)
TABLE 63. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 64. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY OMICS TECHNOLOGY, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 65. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PRODUCT, 2018-2027 (USD MILLION)
TABLE 66. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY REGION, 2018-2027 (USD MILLION)
TABLE 67. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 68. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY STATE, 2018-2027 (USD MILLION)
TABLE 69. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 70. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTIC DEVICES, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 71. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY REGION, 2018-2027 (USD MILLION)
TABLE 72. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 73. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY STATE, 2018-2027 (USD MILLION)
TABLE 74. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 75. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DRUGS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 76. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY REGION, 2018-2027 (USD MILLION)
TABLE 77. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 78. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY STATE, 2018-2027 (USD MILLION)
TABLE 79. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY FOODS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 81. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 82. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 83. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 84. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 85. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY PREBIOTIC & PROBIOTICS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 86. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTIC AREA, 2018-2027 (USD MILLION)
TABLE 87. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 88. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 89. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 90. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY GASTROINTESTINAL DISORDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 92. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 93. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 94. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 95. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY METABOLIC DISORDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 97. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY REGION, 2018-2027 (USD MILLION)
TABLE 98. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 99. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY STATE, 2018-2027 (USD MILLION)
TABLE 100. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY SKIN DISORDERS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 102. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY REGION, 2018-2027 (USD MILLION)
TABLE 103. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 104. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY STATE, 2018-2027 (USD MILLION)
TABLE 105. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY WOMEN’S HEALTH, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 107. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY APPLICATION, 2018-2027 (USD MILLION)
TABLE 108. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 109. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 110. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 111. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 112. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 113. GLOBAL HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY REGION, 2018-2027 (USD MILLION)
TABLE 114. AMERICAS HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 115. UNITED STATES HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY STATE, 2018-2027 (USD MILLION)
TABLE 116. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, BY THERAPEUTICS, BY COUNTRY, 2018-2027 (USD MILLION)
TABLE 118. AMERICAS HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 119. ARGENTINA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 120. BRAZIL HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 121. CANADA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 122. MEXICO HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 123. UNITED STATES HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 124. ASIA-PACIFIC HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 125. AUSTRALIA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 126. CHINA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 127. INDIA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 128. INDONESIA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 129. JAPAN HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 130. MALAYSIA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 131. PHILIPPINES HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 132. SINGAPORE HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 133. SOUTH KOREA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 134. TAIWAN HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 135. THAILAND HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 136. EUROPE, MIDDLE EAST & AFRICA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 137. FRANCE HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 138. GERMANY HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 139. ITALY HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 140. NETHERLANDS HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 141. QATAR HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 142. RUSSIA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 143. SAUDI ARABIA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 144. SOUTH AFRICA HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 145. SPAIN HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 147. UNITED KINGDOM HUMAN MICROBIOME MARKET SIZE, 2018-2027 (USD MILLION)
TABLE 148. GLOBAL HUMAN MICROBIOME MARKET: SCORES
TABLE 149. GLOBAL HUMAN MICROBIOME MARKET: BUSINESS STRATEGY
TABLE 150. GLOBAL HUMAN MICROBIOME MARKET: PRODUCT SATISFACTION
TABLE 151. GLOBAL HUMAN MICROBIOME MARKET: RANKING
TABLE 152. GLOBAL HUMAN MICROBIOME MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 153. GLOBAL HUMAN MICROBIOME MARKET: MERGER & ACQUISITION
TABLE 154. GLOBAL HUMAN MICROBIOME MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 155. GLOBAL HUMAN MICROBIOME MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 156. GLOBAL HUMAN MICROBIOME MARKET: INVESTMENT & FUNDING
TABLE 157. GLOBAL HUMAN MICROBIOME MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 158. GLOBAL HUMAN MICROBIOME MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • 4D pharma PLC
  • AOBiome, LLC
  • Astarte Medical Partners, Inc
  • Axial Therapeutics, Inc.
  • DuPont de Nemours, Inc.
  • Enterome Bioscience
  • Evelo Biosciences, Inc.
  • Exeliom Biosciences SAS
  • Ferring B.V.
  • Finch Therapeutics Group, Inc.
  • Intralytix, Inc.
  • Locus Biosciences, Inc.
  • Merck and Co. Inc.
  • Metabiomics Corporation
  • Osel Inc.
  • Second Genome, Inc.
  • Seres Therapeutics, Inc.
  • Synlogic, Inc.
  • Synthetic Biologics, Inc.
  • Vedanta Biosciences, Inc.
  • Yakult Honsha Co., Ltd.
Note: Product cover images may vary from those shown

Loading
LOADING...